抗菌药物专项整治活动对喹诺酮类药物的影响(3)
第1页 |
参见附件。
参考文献
[1]Wang H,Chen M,China Nosocomial Pathogens Resistance Surveillance Study Group.Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China.1996 t0 2002.Diagn microbial Infect Dis, 2005, 51:201-208.
[2]李家泰,李耘,王进.我国医院和社区获得性感染革兰氏阴性杆菌耐药性监测研究.中华医学杂志,2003,83:1035-1045.
[3]陈民钧,王辉,中国医院内病原菌耐药监测网.中国重症监护病房革兰阴性菌耐药性连续7年监测研究.中华医学杂志、2003.83:375-381.
[4]Reinert RR, Low DE, Rossi F, et al. Antimicrobiul susceptibility among organisms from the Asia/Pacific Rim,Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.J Antimicrob Chemother. 2007, 60:1018-1029.
[4]肖永红,沈平,魏泽庆等。Mohnarin 2011年度全国细菌耐药监测。中华医学感染学杂志,2012,22(22)4946-4952.
[5]汪复1 2005中国CHINET细菌耐药性监测结果.[J]中国感染与化疗杂志,2006,6(5): 289-2951.
[6] Stover CK, Pham XQ, Erwin AL, et al:Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.Nature 2000, 406(6799):959-964.
[7]Danilchanka O, Pavlenok M, Niederweis M. Role of porins for up take
of antibiotics by Mycobacterium Smegmatis.[J]Antimicrob AgentsChemather, 2008, 52( 9) : 3127-3134.
通讯作者:王利菊,医学硕士,大连市友谊医院,呼吸内科。
您现在查看是摘要介绍页,详见PDF附件。